Evidence map›Paper›PMID 30410493›Full record

ReviewFrontiers in immunology2018

Molecular Control of Follicular Helper T cell Development and Differentiation.

Haijing Wu, Yaxiong Deng, Ming Zhao, Jianzhong Zhang, Min Zheng, Genghui Chen, Linfeng Li, Zhibiao He, Qianjin Lu

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Science advances · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Follicular Helper CD4Mediators of inflammation · 2021
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

Haijing WuHunan Key Laboratory of Medical Epigenomics, Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha, China.
Yaxiong DengHunan Key Laboratory of Medical Epigenomics, Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha, China.
Ming ZhaoHunan Key Laboratory of Medical Epigenomics, Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha, China.
Jianzhong ZhangDepartment of Dermatology, Peking University People's Hospital, Beijing, China.
Min ZhengDepartment of Dermatology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Genghui ChenBeijing Wenfeng Tianji Pharmaceuticals Ltd., Beijing, China.
Linfeng LiDepartment of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Zhibiao HeDepartment of Emergency, Second Xiangya Hospital of Central South University, Changsha, China.
Qianjin LuHunan Key Laboratory of Medical Epigenomics, Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha, China.
Central South University · CNSecond Xiangya Hospital of Central South University · CNBeijing Tianheng Pharmaceutical Research Institute · CNCapital Medical University · CNLund University · SEPeking University · CNSecond Affiliated Hospital of Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Follicular helper T cells (Tfh) are specialized helper T cells that are predominantly located in germinal centers and provide help to B cells. The development and differentiation of Tfh cells has been shown to be regulated by transcription factors, such as B-cell lymphoma 6 protein (Bcl-6), signal transducer and activator of transcription 3 (STAT3) and B lymphocyte-induced maturation protein-1 (Blimp-1). In addition, cytokines, including IL-21, have been found to be important for Tfh cell development. Moreover, several epigenetic modifications have also been reported to be involved in the determination of Tfh cell fate. The regulatory network is complicated, and the number of novel molecules demonstrated to control the fate of Tfh cells is increasing. Therefore, this review aims to summarize the current knowledge regarding the molecular regulation of Tfh cell development and differentiation at the protein level and at the epigenetic level to elucidate Tfh cell biology and provide potential targets for clinical interventions in the future.

Indexed as

AnimalsCell DifferentiationEpigenesis, GeneticGene Expression RegulationGerminal CenterHumansInterleukin-21InterleukinsPositive Regulatory Domain I-Binding Factor 1Proto-Oncogene Proteins c-bcl-6STAT3 Transcription FactorT-Lymphocytes, Helper-InducerInterleukin-21InterleukinsPositive Regulatory Domain I-Binding Factor 1Proto-Oncogene Proteins c-bcl-6STAT3 Transcription FactorBcl-6Blimp-1epigeneticsTfhtranscription factors

Identifiers

PMID30410493
PMCPMC6209674
OpenAlexW2898213254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.